The Peter MacCallum Cancer Centre, also known as the Peter MacCallum Cancer Institute and commonly abbreviated as Peter Mac, is an Australian oncology research institute, ...

Melbourne-based Peter MacCallum Cancer Centre has trialled the use of IBM Watson and found it helped reduce the time it takes for clinicians to match lung cancer patients to relevant clinical ...

HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's CAR-T cell therapy in patients with kappa ...

The Peter MacCallum Cancer Centre will celebrate 75 years this year. In that time it has been the home of many lifesaving medical breakthroughs, as researchers continue searching for cancer cures.

PALO ALTO, Calif., Dec. 12, 2017 /PRNewswire/ -- Varian (NYSE: VAR) today announced the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia has selected the Eclipse ™ treatment ...

The Peter MacCallum Cancer Centre in Parkville. Credit: Justin McManus. The study was led by Mark Smyth, who was one of Australia’s foremost cancer researchers until 2021, ...

The government said the centre remained on track to meet its annual targets for planned surgery this year. Posted 29 Jan 2023 29 Jan 2023 Sun 29 Jan 2023 at 1:05am , updated 29 Jan 2023 29 Jan ...

Peter MacCallum Cancer Centre’s major nuclear cancer breakthrough to hurt drug giant Novartis. Nuclear medicine is emerging as a new way of treating many cancers.

Peter MacCallum Cancer Centre's chair has quit following a dispute with the Government over private beds.(ABC News) Help keep family & friends informed by sharing this article.

NASHUA, N.H. and MELBOURNE, Australia, May 01, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy ...

Peter MacCallum Cancer Centre, Lead Scientist, Solid Somatic Molecular Pathology Laboratory BIOGRAPHY. Abstract. Next-generation sequencing (NGS) has become increasingly popular with testing labs, as ...

Microarray technology will initially be used to study ovarian cancer and carcinoma. Affymetrix entered into a five-year collaboration with the Peter MacCallum Cancer Centre in Melbourne, Australia ...